Bessemer Group Inc. Reduces Stake in Merit Medical Systems, Inc. $MMSI

Bessemer Group Inc. reduced its stake in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) by 23.2% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 241,228 shares of the medical instruments supplier’s stock after selling 72,753 shares during the quarter. Bessemer Group Inc.’s holdings in Merit Medical Systems were worth $16,629,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Wellington Management Group LLP lifted its stake in shares of Merit Medical Systems by 377.7% in the 3rd quarter. Wellington Management Group LLP now owns 1,240,509 shares of the medical instruments supplier’s stock valued at $103,248,000 after purchasing an additional 980,823 shares during the last quarter. Norges Bank bought a new position in shares of Merit Medical Systems during the 4th quarter valued at approximately $75,957,000. Iron Triangle Partners LP bought a new position in shares of Merit Medical Systems during the 4th quarter valued at approximately $33,992,000. Champlain Investment Partners LLC bought a new position in shares of Merit Medical Systems during the 4th quarter valued at approximately $32,359,000. Finally, Fifth Third Bancorp raised its holdings in Merit Medical Systems by 24,625.6% during the 1st quarter. Fifth Third Bancorp now owns 313,026 shares of the medical instruments supplier’s stock valued at $21,577,000 after buying an additional 311,760 shares during the period. 99.66% of the stock is currently owned by hedge funds and other institutional investors.

Merit Medical Systems Price Performance

MMSI opened at $73.99 on Friday. The company has a market capitalization of $4.41 billion, a price-to-earnings ratio of 32.03, a PEG ratio of 2.30 and a beta of 0.52. The company has a current ratio of 5.08, a quick ratio of 3.46 and a debt-to-equity ratio of 0.45. Merit Medical Systems, Inc. has a 12-month low of $59.74 and a 12-month high of $94.75. The business’s fifty day simple moving average is $66.96 and its 200-day simple moving average is $72.63.

Merit Medical Systems (NASDAQ:MMSI) last released its quarterly earnings data on Thursday, April 30th. The medical instruments supplier reported $0.94 earnings per share for the quarter, beating the consensus estimate of $0.84 by $0.10. Merit Medical Systems had a return on equity of 13.54% and a net margin of 9.03%.The firm had revenue of $381.88 million during the quarter, compared to the consensus estimate of $377.59 million. During the same period in the previous year, the company posted $0.86 earnings per share. The firm’s quarterly revenue was up 7.4% on a year-over-year basis. Merit Medical Systems has set its FY 2026 guidance at 4.010-4.150 EPS. On average, equities research analysts anticipate that Merit Medical Systems, Inc. will post 3.62 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on MMSI shares. Barrington Research lowered their price target on Merit Medical Systems from $109.00 to $107.00 and set an “outperform” rating for the company in a research report on Monday, April 20th. Citigroup reiterated an “outperform” rating on shares of Merit Medical Systems in a research report on Monday, April 20th. Piper Sandler reissued an “overweight” rating on shares of Merit Medical Systems in a research note on Friday, July 10th. Needham & Company LLC lowered their target price on shares of Merit Medical Systems from $101.00 to $90.00 and set a “buy” rating for the company in a report on Friday, May 1st. Finally, Weiss Ratings lowered shares of Merit Medical Systems from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Friday, May 8th. Eight research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $92.80.

Insider Transactions at Merit Medical Systems

In other Merit Medical Systems news, insider Brian G. Lloyd purchased 2,000 shares of Merit Medical Systems stock in a transaction dated Thursday, May 7th. The stock was acquired at an average price of $62.62 per share, for a total transaction of $125,240.00. Following the acquisition, the insider owned 2,000 shares in the company, valued at $125,240. This trade represents a ∞ increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Lynne N. Ward sold 5,000 shares of the business’s stock in a transaction dated Thursday, May 7th. The shares were sold at an average price of $62.61, for a total transaction of $313,050.00. Following the completion of the sale, the director owned 7,809 shares of the company’s stock, valued at approximately $488,921.49. This represents a 39.04% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 0.70% of the company’s stock.

Merit Medical Systems Profile

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.